3rd Drug Discovery Nexus Summit
The Nexus of Discovery
After record participation by attendees, speakers, sponsors & exhibitors in 2018, we are back with its 3rd edition on 23rd & 24th May 2019 in Munich, Germany. 3rd DDN will feature prominent scientists in both academia & industry to share & discuss the latest advancements in drug discovery. 2019's event will feature new streams, focusing on the latest trends in drug discovery. 3rd DDN will bring together leading experts to discuss challenges from target identification to pre-clinical studies. The event will feature opening and closing plenary keynote sessions, eight conference tracks, interactive breakout discussion groups and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of precise drug discovery.
About 3rd Drug Discovery Nexus
Peculiar Conference Format
Poster Sessions
Pre-qualified one to one meetings
Panel Discussions
Exhibition Space
Keynote Presentations
Tailor fit & Personalized Agenda
What we offer
- Enrich topics
- Meet experts & influencers face to face
- Focused Networking
- Information about the valuable insights of industry
- Virtual synchronization
- Pronouncement Authority
- Distinct Contrast
- Position yourself as an expert
- Direct contact with potential clients and costumers
- Get fresh ideas and solutions for your business
- Stay current with trends by learning from powerful speakers
- Observe visual cues from presenters & other attendees
- Gain insight into how new techniques are being utilized to discover new drugs
-
-
- CSO
- Head, Biology & Translational Pharmacology
- Head, Oncology Chemistry
- Dir Discovery Chemistry & Technology
- Head of Molecular & Computational Toxicology
- VP, R&D
- Director DMPK
- CMO
- Head, Cancer Biology & Pharmacology
- Dir CAR Program, Research & Discovery
- Chief Scientist, R&D
- Director R&D Management
- Director Biomarker Discovery
- Senior Director Preclinical
- Director Pharmacology
- Senior Group Leader Medicinal Chemistry
- VP Preclinical R&D
- VP Chemistry
- Director Preclinical Research
- Director Preclinical Drug Safety
- Head, PTS Discovery Genome Editing
-
- Target identification & validation
- Medicinal Chemistry/Drug Discovery Chemistry
- Chimeric DNA
- NAPDD
- Disease-oriented trials
- Pre-Clinical Accessions
- Disease-Specific sessions
- Modern Drug Discovery


You don’t want to miss this
- 05/23/2019
- 17 Speakers
- Tickets
meet our speaking talents
Sponsors




